Peritoneal Dialysis Market

The report "Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals)- Global Forecast to 2031", is projected to grow from USD 10.04 billion in 2026 and to reach USD 14.16 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.

Browse 280 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals)- Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/peritoneal-dialysis-market-211750966.html

Patients and care providers have been preferring peritoneal dialysis to hemodialysis because of its convenience, low infection rates, and excellent quality of life. In fact, it allows patients to receive dialysis at home, which is a major advantage in avoiding frequent hospital visits; hence, patients will enjoy more flexibility in their schedules for treatment delivery. Such freedom to carry on with one's daily work, social life, and, most importantly, one's home life is indeed highly welcome by those who do not want to disrupt their work and social lives by being taken out of their homes to visit a dialysis center a few times a week. Second, bloodstream infections have been reported less with PD than with hemodialysis, which accesses the bloodstream via a fistula or catheter, thereby increasing the risk of infection. PD, on the other hand, utilizes natural filters provided by the peritoneal membrane in the abdomen, which considerably reduces the risk of infection and its consequences. Owing to these facts, both patients and healthcare providers recognize that PD has become a better, more patient-oriented dialysis modality.

This report categorizes the peritoneal dialysis market based on offering, modality, disease indication, end user, and region.

“The peritoneal solution bags segment accounts for the largest share of the peritoneal dialysis market”

The market share for peritoneal dialysis solution bags was the largest because these are one-time, single-use consumables that require continuous replenishment. In contrast to a dialysis machine, which is purchased only once, solution bags must be used every day, with demand consistently high. Consequently, a constant revenue stream will be created for manufacturers and suppliers. Patients on peritoneal dialysis also require a minimum number of bags per day, thereby increasing consumption. The reason why the solution bag segment remains on top in this market for peritoneal dialysis is that these bags are used and replaced at a high rate.

“The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment holds the largest market share of the peritoneal dialysis market.”

Continuous Ambulatory Peritoneal Dialysis (CAPD) has been associated with good patient outcomes, notably the longer preservation of residual kidney function compared to hemodialysis. CAPD's gentle and continuous nature helps reduce stress on the kidneys, allowing patients to retain their ability at least for a long time. Moreover, the number of hospitalizations in CAPD patients is much smaller in comparison with hemodialysis patients, and this is mainly because of the home-based mode of treatment, as it reduces the threat of infections and complications possible at clinical levels. All these make CAPD patients healthier, with a higher quality of life and lower healthcare costs.

 “The Asia Pacific region is expected to exhibit the highest growth rate during the forecast period.”

This is mainly driven by proactive healthcare reforms and policies initiated by governments in these nations for better access to dialysis treatments. Such measures concentrate on hospital infrastructures and making such basic dialysis facilities accessible to low-income groups. This includes increasing healthcare programs, then funding and subsidizing treatment costs, and raising public awareness of kidney disease and its management among governments as a strategy to address such significant disparities in access to healthcare. In that case, commitment towards improved healthcare delivery for underserved populations fosters a more inclusive environment to support peritoneal dialysis, which further drives the market growth in the region.  

Key Market Players:

Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Vantive (US), Fresenius Medical Care AG (Germany), Mozarc Medical (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US), Utah Medical Products, Inc. (US), Terumo Corporation (Japan), Diaverum AB (Sweden), Medionics (Canada), Newsol Technologies (Canada), Apollo Dialysis Pvt Ltd (India), U.S. Renal Care, Inc. (US), Northwest Kidney Centers (US), Relavo (US), Mitra Industries Pvt Ltd (India), JMS Co., Ltd. (Japan), AMECATH (Egypt), Polymedicure (India), Huaren Pharmaceutical (China), AWAK Technologies (Singapore), Innovative Renal Care (US), Romsons (India), SSEM Mthembu Medical (Pty) Ltd (South Africa),  Renax Biomedical Technology Co., Ltd (China), and Advin Health Care (India).

Don’t miss out on business opportunities in Peritoneal Dialysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com